PubMed

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis.

Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, de Jong PE, de Zeeuw D, Shahinfar S, Toto R, Levey AS; AIPRD Study Group.

Ann Intern Med. 2003 Aug 19;139(4):244-52.PMID: 12965979 [PubMed - indexed for MEDLINE]Related articlesFree article

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.

Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, Maschio G, Brenner BM, Kamper A, Zucchelli P, Becker G, Himmelmann A, Bannister K, Landais P, Shahinfar S, de Jong PE, de Zeeuw D, Lau J, Levey AS.

Ann Intern Med. 2001 Jul 17;135(2):73-87. Erratum in: Ann Intern Med 2002 Aug 20;137(4):299. PMID: 11453706 [PubMed - indexed for MEDLINE]Related articlesFree article

Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease.

Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, Marcantoni C, de Jong PE, de Zeeuw D, Shahinfar S, Ruggenenti P, Remuzzi G, Levey AS; AIPRD Study Group. Angiotensin-Converting Enzymne Inhibition and Progression of Renal Disease.

Kidney Int. 2001 Sep;60(3):1131-40.PMID: 11532109 [PubMed - indexed for MEDLINE]Related articlesFree article

The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease.

Jafar TH, Stark PC, Schmid CH, Strandgaard S, Kamper AL, Maschio G, Becker G, Perrone RD, Levey AS; ACE Inhibition in Progressive Renal Disease (AIPRD) Study Group.

Kidney Int. 2005 Jan;67(1):265-71.PMID: 15610250 [PubMed - indexed for MEDLINE]Related articles

Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group.

Giatras I, Lau J, Levey AS.

Ann Intern Med. 1997 Sep 1;127(5):337-45.PMID: 9273824 [PubMed - indexed for MEDLINE]Related articlesFree article

Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.

Suzuki H, Kanno Y, Nakamoto H, Okada H, Sugahara S.

Clin Exp Hypertens. 2005 Feb-Apr;27(2-3):129-38.PMID: 15835375 [PubMed - indexed for MEDLINE]Related articles

Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.

Ruggenenti P, Perna A, Gherardi G, Benini R, Remuzzi G.

Am J Kidney Dis. 2000 Jun;35(6):1155-65.PMID: 10845831 [PubMed - indexed for MEDLINE]Related articles

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)

[No authors listed]

Lancet. 1997 Jun 28;349(9069):1857-63.PMID: 9217756 [PubMed - indexed for MEDLINE]Related articles

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.PMID: 16095545 [PubMed - indexed for MEDLINE]Related articlesFree article

Randomized controlled crossover study of the effect on proteinuria and blood pressure of adding an angiotensin II receptor antagonist to an angiotensin converting enzyme inhibitor in normotensive patients with chronic renal disease and proteinuria.

Kincaid-Smith P, Fairley K, Packham D.

Nephrol Dial Transplant. 2002 Apr;17(4):597-601. Erratum in: Nephrol Dial Transplant 2002 Jun;17(6):1153. PMID: 11917051 [PubMed - indexed for MEDLINE]Related articlesFree article

Summaries for patients. Blood pressure and urine protein levels with the least risk for worsening kidney disease.

[No authors listed]

Ann Intern Med. 2003 Aug 19;139(4):I36. No abstract available. PMID: 12965997 [PubMed - indexed for MEDLINE]Related articlesFree article

Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.

Tylicki L, Rutkowski P, Renke M, Larczyński W, Aleksandrowicz E, Lysiak-Szydlowska W, Rutkowski B.

Am J Kidney Dis. 2008 Sep;52(3):486-93. Epub 2008 Apr 18.PMID: 18423812 [PubMed - indexed for MEDLINE]Related articles

Treatment of hypertension in chronic kidney disease.

Toto RD.

Semin Nephrol. 2005 Nov;25(6):435-9. Review.PMID: 16298269 [PubMed - indexed for MEDLINE]Related articles

Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.

Minutolo R, Gabbai FB, Borrelli S, Scigliano R, Trucillo P, Baldanza D, Laurino S, Mascia S, Conte G, De Nicola L.

Am J Kidney Dis. 2007 Dec;50(6):908-17.PMID: 18037091 [PubMed - indexed for MEDLINE]Related articles

Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?

Weir MR.

Clin Ther. 2007 Sep;29(9):1803-24. Review.PMID: 18035185 [PubMed - indexed for MEDLINE]Related articles

Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).

Ruggenenti P, Perna A, Mosconi L, Pisoni R, Remuzzi G.

Kidney Int. 1998 May;53(5):1209-16.PMID: 9573535 [PubMed - indexed for MEDLINE]Related articlesFree article

The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis.

Jafar TH, Schmid CH, Stark PC, Toto R, Remuzzi G, Ruggenenti P, Marcantoni C, Becker G, Shahinfar S, De Jong PE, De Zeeuw D, Kamper AL, Strangaard S, Levey AS.

Nephrol Dial Transplant. 2003 Oct;18(10):2047-53.PMID: 13679479 [PubMed - indexed for MEDLINE]Related articlesFree article

The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study.

Sarnak MJ, Greene T, Wang X, Beck G, Kusek JW, Collins AJ, Levey AS.

Ann Intern Med. 2005 Mar 1;142(5):342-51.PMID: 15738453 [PubMed - indexed for MEDLINE]Related articlesFree article

Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels.

Agarwal R, Siva S, Dunn SR, Sharma K.

Am J Kidney Dis. 2002 Mar;39(3):486-92.PMID: 11877567 [PubMed - indexed for MEDLINE]Related articles

Add-on angiotensin receptor blocker in patients who have proteinuric chronic kidney diseases and are treated with angiotensin-converting enzyme inhibitors.

Kanno Y, Takenaka T, Nakamura T, Suzuki H.

Clin J Am Soc Nephrol. 2006 Jul;1(4):730-7. Epub 2006 May 17.PMID: 17699280 [PubMed - indexed for MEDLINE]Related articlesFree article